Report Categories
View AllRecent Articles
View All
Investors Eye Nvidias Road Ahead RDS Wealth CEO Dale Smothers on Key Catalysts This Week
Jefferson Capital JCAP Q1 2026 Earnings Miss Sparks Concern
NextCure NXTC Q1 2026 Earnings 187 EPS Surges Past 215 Estimates
Gabelli GLU Stock Slides 118 Support at 1833 20260518
Lincoln International Valued at 23 Billion as Shares Jump in NYSE Debut
Nvidias 80 Billion Stock Buyback and Dividend Hike Could Mirror Apples Shareholder Returns Strategy
Nuvectis Pharma NVCT Surges 282 Nearing 1148 Resistance 20260521
RYAM Q1 2026 Earnings Massive EPS Miss Clouds Outlook Despite Positive Stock Reaction
New York Fed Study Surging Gas Prices Disproportionately Burden LowerIncome Households
Veteran Trader Steve Burns Issues Bear Market Warning Highlights Three Investor Pitfalls
GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise
Hybrid Manufacturing Gains Traction in Mexico Additive and Machining Converge
Sportradar Securities Class Action Deadline Approaching Rosen Law Firm Reminds Investors
ParkerHannifin Reportedly Set to Acquire Circor Aerospace from KKR
CBLL Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable Stock Edges Lower
BOX Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Pullback
CLS Q1 2026 Earnings Beat and Raise as Celestica Delivers Strong EPS Surprise
SKM Q4 2025 Earnings EPS Miss and Stock Decline Signal Caution
FGBIP Q1 2026 Earnings Strong EPS Beat Amid Quiet Market Reaction
External Links
Kevin Warsh to Be Sworn in as Federal Reserve Chair on Friday
SNY Q1 2026 Earnings EPS Surpasses Expectations Amidst Limited Revenue Disclosure
Stem Inc Q1 2026 Earnings EPS Surprises to the Upside as Stock Rises
Alight Inc Q1 2026 Earnings EPS Surprise Beats Estimates Stock Edges Higher
BBAI Q1 2026 Earnings EPS Misses Estimates as Losses Widen
Castle Biosciences Inc CSTL Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Optimism
Scholastic Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline
Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status
YSS Q1 2026 Earnings Massive EPS Miss Amid Broader Sector Headwinds